GlassScriptPhysician profile
Julius O Ajayi
NPI 1013189364
$4,017.34
in general payments reported to CMS, 2019-2025
30 companies · $600 in 2025
The $600 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $363 · 2021: $543 · 2022: $450 · 2023: $531 · 2024: $523 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344 · Education: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.76 |
| Education | $309.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $974.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $645.26 | 2019-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $512.81 | 2021-2024 | |
| Astellas Pharma US INC | $438.68 | 2019-2024 | Veozah |
| Pfizer INC. | $217.82 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $151.56 | 2019-2025 | Gardasil 9, Capvaxive |
| Lilly USA, LLC | $150.60 | 2020-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $130.58 | 2019-2021 | |
| Amgen INC. | $101.67 | 2025 | Krystexxa, Repatha |
| Amarin Pharma, INC. | $100.00 | 2019-2022 | |
| Vbi Vaccine (Delaware) INC. | $63.40 | 2022-2023 | Prehevbrio |
| Abbott Laboratories | $59.64 | 2019-2023 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $57.52 | 2024 | Inspire |
| Allergan, INC. | $52.20 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.51 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $36.65 | 2020-2021 | |
| Horizon Therapeutics Plc | $31.77 | 2023 | Krystexxa |
| Exact Sciences Corporation | $30.85 | 2024 | Cologuard Collection Kit |
| Teleflex LLC | $25.72 | 2024 | Urolift |
| Otsuka America Pharmaceutical, INC. | $22.15 | 2020 | |
| Intuitive Surgical, INC. | $22.00 | 2022 | |
| Abbvie INC. | $21.52 | 2021 | |
| Corcept Therapeutics | $20.76 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.60 | 2022 | |
| Glaxosmithkline, LLC. | $18.34 | 2024 | Arexvy, Shingrix |
| Arbor Pharmaceuticals, INC. | $17.49 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.53 | 2019 | |
| Dexcom, INC. | $14.00 | 2025 | Dexcom G6 Transmitter |
| Linus Health, INC. | $13.53 | 2024 | Core Cognitive Evaluation |
| Nevro Corp. | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julius Ajayi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.